Ian Page

Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom.

National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005.

Genera dd engages in the production and sale of veterinary and plant protection products. Its products are vitamin and mineral supplements, insecticides, herbicides, and fungicides. The company was founded in 1901 and is headquartered in Rakov Potok, Croatia.

Dechra Veterinary Products NZ Ltd. distributes veterinary pharmaceutical products. Its products include Aloveen Shampoo & Conditioner, Canaural, Cat Lax, Clinacin, Conoptal, Cyclo Spray and Equipalazone. The company is headquartered in Paraparaumu Beach, New Zealand.

Dechra Veterinary Products Ltd. engages in the development of branded pharmaceuticals for companion animals. The company is headquartered in Shrewsbury, the United Kingdom.

Dechra Investments Ltd. operates as a investment holding company. The company is headquartered in Northwich, the United Kingdom.

Part of Dechra Pharmaceuticals Plc, Dechra Ltd. provides veterinary services. The company is based in Skipton, UK and was founded in 2002.

Medical Ethics Pty Ltd. engages in the development of technology for the treatment of wounds of humans and animals. Its products include Medi-Solfen Human, Tri-Solfen Animal, and Rapid Transdermal Analgesic Animal. The company was founded by Allan Giffard, Meredith Sheil, and Charles Olsson and is headquartered in Melbourne, Australia.

Part of Dechra Pharmaceuticals Plc, Dechra Finance Sterling Ltd. provides finance services. The company is based in Northwich, UK and was founded in 2016.